Skip to main content
Header image

Gurská Soňa Ph.D.

Journals

VELAVAPALLI, V., V. MADDIPATI, S. GURSKÁ, N. ANNADURAI, B. LIŠKOVÁ, N. KATARI, P. DŽUBÁK, M. HAJDÚCH, V. DAS, R. GUNDLA
Novel 5-Substituted Oxindole Derivatives as Bruton's Tyrosine Kinase Inhibitors: Design, Synthesis, Docking, Molecular Dynamics Simulation, and Biological Evaluation. ACS Omega. 2024, 7(9), 8067-8081, ISSN: 2470-1343, PMID: 38405484,
GUTIERREZ, J., H. RAMIREZ, E. FERNANDEZ-MOREIRA, M. ACOSTA, M. MIJARES, J. DE SANCTIS, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, L. LABRADOR-FAGÚNDEZ, B. STELLA, L. DIAZ-PEREZ, G. BENAIM, J. CHARRIS
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives. Pharmaceuticals . 2023, 16(12), 1709, ISSN: 1424-8247, PMID: 38139835,
KORABOINA, C., V. MADDIPATI, N. ANNADURAI, S. GURSKÁ, P. DŽUBÁK, M. HAJDÚCH, V. DAS, R. GUNDLA
Synthesis and Biological Evaluation of Oxindole Sulfonamide Derivatives as Bruton's Tyrosine Kinase Inhibitors. ChemMedChem. 2023, ISSN: 1860-7179, PMID: 37916435,

Books & book chapters

Analysis of cytotoxicity by tetrazolium salt reduction test , 1.vyd., Olomouc, Palacky University, 2021, 10, 67-72, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

RNA ISOLATION KIT (Džubák)

Utility Model: CZ 35067. Granted: 18.5.2021. Ownership: Palacky University, Olomouc. Inventors: Džubák Petr, Hajdúch Marián, Gurská Soňa, Koudeláková Vladimíra, Jaworek Hana.

Status: Available

Master mentorship

Synek Vojtěch

Development of the assay for measurement of the CA activity and its implementation into HTS

Status: Graduated from 2018 to 2020.
Dostálová Kristýna

Cell-based assays for high-throughput screening in drug discovery

Status: Graduated from 2014 to 2016.
Voltemarová Tereza

Cytotoxicity profiling of new potentially bioactive compounds using high throughput screening (HTS)

Status: Graduated from 2019 to 2021.

Bachelor mentorship

Jamborová Petra

Establishment and characterization of anticancer drug resistant leukemic cell lines

Status: Ongoing from 2023.
Synek Vojtěch

Cytotoxicity tests for high-throughput drug discovery

Status: Graduated from 2014 to 2018.
Zabáková Dominika

Analysis of the cytotoxic effects of new chemical substances in HTS conditions

Status: Graduated from 2021 to 2021.